These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 16452498)
1. N-acetyl-seryl-aspartyl-lysyl-proline ameliorates the progression of renal dysfunction and fibrosis in WKY rats with established anti-glomerular basement membrane nephritis. Omata M; Taniguchi H; Koya D; Kanasaki K; Sho R; Kato Y; Kojima R; Haneda M; Inomata N J Am Soc Nephrol; 2006 Mar; 17(3):674-85. PubMed ID: 16452498 [TBL] [Abstract][Full Text] [Related]
2. N-Acetyl-seryl-aspartyl-lysyl-proline inhibits TGF-beta-mediated plasminogen activator inhibitor-1 expression via inhibition of Smad pathway in human mesangial cells. Kanasaki K; Koya D; Sugimoto T; Isono M; Kashiwagi A; Haneda M J Am Soc Nephrol; 2003 Apr; 14(4):863-72. PubMed ID: 12660320 [TBL] [Abstract][Full Text] [Related]
3. Ac-SDKP ameliorates the progression of lupus nephritis in MRL/lpr mice. Tan H; Zhao J; Wang S; Zhang L; Wang H; Huang B; Liang Y; Yu X; Yang N Int Immunopharmacol; 2012 Dec; 14(4):401-9. PubMed ID: 22922317 [TBL] [Abstract][Full Text] [Related]
4. New anti-fibrotic mechanisms of n-acetyl-seryl-aspartyl-lysyl-proline in silicon dioxide-induced silicosis. Sun Y; Yang F; Yan J; Li Q; Wei Z; Feng H; Wang R; Zhang L; Zhang X Life Sci; 2010 Aug; 87(7-8):232-9. PubMed ID: 20624403 [TBL] [Abstract][Full Text] [Related]
5. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal inflammation and tubulointerstitial fibrosis in rats. Wang M; Liu R; Jia X; Mu S; Xie R Int J Mol Med; 2010 Dec; 26(6):795-801. PubMed ID: 21042772 [TBL] [Abstract][Full Text] [Related]
6. N-acetyl-seryl-aspartyl-lysyl-proline attenuates renal injury and dysfunction in hypertensive rats with reduced renal mass: council for high blood pressure research. Liao TD; Yang XP; D'Ambrosio M; Zhang Y; Rhaleb NE; Carretero OA Hypertension; 2010 Feb; 55(2):459-67. PubMed ID: 20026760 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II type I receptor blockade suppresses glomerular renin-angiotensin system activation, oxidative stress, and progressive glomerular injury in rat anti-glomerular basement membrane glomerulonephritis. Kinoshita Y; Kondo S; Urushihara M; Suga K; Matsuura S; Takamatsu M; Shimizu M; Nishiyama A; Kawachi H; Kagami S Transl Res; 2011 Oct; 158(4):235-48. PubMed ID: 21925120 [TBL] [Abstract][Full Text] [Related]
8. N-acetyl-seryl-aspartyl-lysyl-proline inhibits DNA synthesis in human mesangial cells via up-regulation of cell cycle modulators. Kanasaki K; Haneda M; Sugimoto T; Shibuya K; Isono M; Isshiki K; Araki S; Uzu T; Kashiwagi A; Koya D Biochem Biophys Res Commun; 2006 Apr; 342(3):758-65. PubMed ID: 16497271 [TBL] [Abstract][Full Text] [Related]
9. Role of myofibroblasts, macrophages, transforming growth factor-beta endothelin, angiotensin-II, and fibronectin in the progression of tubulointerstitial nephritis induced by gentamicin. Geleilete TJ; Melo GC; Costa RS; Volpini RA; Soares TJ; Coimbra TM J Nephrol; 2002; 15(6):633-42. PubMed ID: 12495276 [TBL] [Abstract][Full Text] [Related]
10. N-acetyl-seryl-aspartyl-lysyl-proline mediates the anti-fibrotic properties of captopril in unilateral ureteric obstructed BALB/C mice. Chan GCW; Wu HJ; Chan KW; Yiu WH; Zou A; Huang XR; Lan HY; Lai KN; Tang SCW Nephrology (Carlton); 2018 Apr; 23(4):297-307. PubMed ID: 28075040 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor165 resolves glomerular inflammation and accelerates glomerular capillary repair in rat anti-glomerular basement membrane glomerulonephritis. Shimizu A; Masuda Y; Mori T; Kitamura H; Ishizaki M; Sugisaki Y; Fukuda Y J Am Soc Nephrol; 2004 Oct; 15(10):2655-65. PubMed ID: 15466270 [TBL] [Abstract][Full Text] [Related]
12. Prevention of aortic fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in angiotensin II-induced hypertension. Lin CX; Rhaleb NE; Yang XP; Liao TD; D'Ambrosio MA; Carretero OA Am J Physiol Heart Circ Physiol; 2008 Sep; 295(3):H1253-H1261. PubMed ID: 18641275 [TBL] [Abstract][Full Text] [Related]
13. Prevention of myocardial fibrosis by N-acetyl-seryl-aspartyl-lysyl-proline in diabetic rats. Castoldi G; di Gioia CR; Bombardi C; Perego C; Perego L; Mancini M; Leopizzi M; Corradi B; Perlini S; Zerbini G; Stella A Clin Sci (Lond); 2009 Oct; 118(3):211-20. PubMed ID: 20310083 [TBL] [Abstract][Full Text] [Related]
14. N-Acetyl-Seryl-Aspartyl-Lysyl-Proline: mechanisms of renal protection in mouse model of systemic lupus erythematosus. Liao TD; Nakagawa P; Janic B; D'Ambrosio M; Worou ME; Peterson EL; Rhaleb NE; Yang XP; Carretero OA Am J Physiol Renal Physiol; 2015 May; 308(10):F1146-54. PubMed ID: 25740596 [TBL] [Abstract][Full Text] [Related]
15. d-amino acid modification protects N-Acetyl-seryl-aspartyl-lysyl-proline from physiological hydroxylation and increases its antifibrotic effects on hepatic fibrosis. Zhang X; Zhou J; Zhu Y; He L; Pang Z; Wang Z; Xu C; Zhang C; Hao Q; Li W; Zhang W; Zhang Y; Li M IUBMB Life; 2019 Sep; 71(9):1302-1312. PubMed ID: 30900390 [TBL] [Abstract][Full Text] [Related]
16. Blockade of TGF-beta action ameliorates renal dysfunction and histologic progression in anti-GBM nephritis. Zhou A; Ueno H; Shimomura M; Tanaka R; Shirakawa T; Nakamura H; Matsuo M; Iijima K Kidney Int; 2003 Jul; 64(1):92-101. PubMed ID: 12787399 [TBL] [Abstract][Full Text] [Related]
17. Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis. Iyoda M; Shibata T; Wada Y; Kuno Y; Shindo-Hirai Y; Matsumoto K; Akizawa T Nephrol Dial Transplant; 2013 Mar; 28(3):576-84. PubMed ID: 23045430 [TBL] [Abstract][Full Text] [Related]
18. Effect of heparan sulphate on kidney tissue expression of TGF-beta, rhoA, laminin and fibronectin in subtotally nephrectomized rats. Bernardini N; Cupisti A; Mattii L; Segnani C; Dolf A; Barsotti M; Barsotti G J Nephrol; 2002; 15(5):530-8. PubMed ID: 12455720 [TBL] [Abstract][Full Text] [Related]